Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04807218 · ClinicalTrials.gov registry record · NA
Virta Intervention in CommuniTies in cOloRado (VICTOR-Pilot)
A NA study of Diabetes Mellitus, Type 2, sponsored by Colorado Prevention Center.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 3
- Study locations
NCT04807218: Completed NA study of Diabetes Mellitus, Type 2, sponsored by Colorado Prevention Center.
NCT04807218 is a NA study of Diabetes Mellitus, Type 2 that has completed, run by Colorado Prevention Center. The registered enrollment target is 51 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04807218, a NA study of Diabetes Mellitus, Type 2, has completed, sponsored by Colorado Prevention Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 3
- Study locations
Study Summary
The VICTOR study plans to include rural communities served by Colorado Heart Healthy Solutions (CHHS) program and find out whether participants will accept a referral to a comprehensive virtual lifestyle intervention, Virta Health. The Virta Health program induces nutritional ketosis to improve glucose control in individuals with type 2 diabetes. The study will inform the acceptability of the referral, the retention of participants in lifestyle intervention, and the durability of effects on glucose control after the lifestyle intervention has ended.
Primary Outcome
Change from baseline hemoglobin A1c (Percent) among patients referred to continuous remote care (Group 1) versus standard care (Group 2)
Conditions Studied
Interventions
- BEHAVIORAL Virta Health
Study Locations (3)
Colorado
- Northwest Colorado Health - Community Health Center & Prevention Services Craig - Craig
- High Plains Community Health Center - Lamar
- Chaffee County Public and Environmental Health - Salida
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2021-03-02 |
| Est. Completion | 2024-08-30 |
| Phase | NA |
What the finished NCT04807218 record still lists
NCT04807218 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Virta Health is the first listed.
NCT04807218 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04807218 about?
NCT04807218 is a clinical study titled "Virta Intervention in CommuniTies in cOloRado (VICTOR-Pilot)". The VICTOR study plans to include rural communities served by Colorado Heart Healthy Solutions (CHHS) program and find out whether participants will accept a referral to a comprehensive virtual lifestyle intervention, Virta Health. The Virta Health program induces nutritional ketosis to improve gluc...
What is the current status of trial NCT04807218?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2021-03-02. Estimated completion is 2024-08-30.
What conditions does trial NCT04807218 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.
What interventions are being tested in trial NCT04807218?
The interventions under investigation include: Virta Health (BEHAVIORAL).
Who is sponsoring clinical trial NCT04807218?
This trial is sponsored by Colorado Prevention Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04807218 being conducted?
This trial has 3 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04807218's enrollment target sits among peer trials
51 257th of 348 higher than 91 of 348 other Diabetes Mellitus, Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI